Arão Belitardo Oliveira1, Reinaldo Teixeira Ribeiro1, Marco Tulio Mello2, Sergio Tufik3, Mario Fernando Prieto Peres4,5. 1. Departamento de Neurologia e Neurocirurgia, Universidade Federal de São Paulo, São Paulo, Brazil. 2. Departamento de Ciências do Esporte, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil. 3. Departamento de Psicobiologia, Universidade Federal de São Paulo, São Paulo, Brazil. 4. Hospital Israelita Albert Einstein, Instituto do Cérebro, São Paulo, Brazil. 5. Instituto de Psiquiatria, Hospital das Clínicas da Faculdade de Medicina, Universidade de São Paulo, São Paulo, Brazil.
Abstract
Introduction: Since endocannabinoids have been implicated in migraine pathophysiology, we conducted a randomized, controlled clinical trial to test the effects of a 12-week aerobic exercise intervention on plasma anandamide (AEA) and its relation with clinical, psychological, and cardiorespiratory outcomes. Materials and Methods: Episodic migraine patients taking no preventive drugs and nonheadache individuals were recruited from Hospital São Paulo and a tertiary headache clinic between March 2012 and March 2015. Participants were randomly assigned to receive aerobic exercise or enter the waitlist. Primary outcome was changes in plasma AEA; secondary outcome was number of days with migraine/month; and other clinical variables, mood scores, and cardiorespiratory fitness were chosen as tertiary outcomes. Measurements were taken on headache-free days. Data were analyzed by generalized linear models. Discussion: Fifty participants concluded the study (mean±SD age=36.2±10.9, and BMI=26.5±4.5). The plasma AEA reduced in migraine exercise (p<0.05) and control exercise groups (p<0.01). The number of days with migraine (p<0.01), migraine attacks (p<0.05), and abortive medication used (p<0.05) reduced in the migraine exercise group, whereas cardiorespiratory fitness increased in migraine exercise and control exercise groups (both p<0.05). Anxiety, depression, anger, and fatigue scores improved in the migraine exercise group (p<0.05 for all). Significant correlations between reduction in abortive medication used and cardiorespiratory fitness (r=-0.81 p<0.001), and reduced AEA (r=0.68 p<0.05) were found. Conclusions: This study suggests that peripheral AEA metabolism may be partly linked to the clinical and cardiorespiratory benefits of regular aerobic exercise in migraine patients. Trials registration: #NCT01972607. Copyright 2019, Mary Ann Liebert, Inc., publishers.
RCT Entities:
Introduction: Since endocannabinoids have been implicated in migraine pathophysiology, we conducted a randomized, controlled clinical trial to test the effects of a 12-week aerobic exercise intervention on plasma anandamide (AEA) and its relation with clinical, psychological, and cardiorespiratory outcomes. Materials and Methods: Episodic migrainepatients taking no preventive drugs and nonheadache individuals were recruited from Hospital São Paulo and a tertiary headache clinic between March 2012 and March 2015. Participants were randomly assigned to receive aerobic exercise or enter the waitlist. Primary outcome was changes in plasma AEA; secondary outcome was number of days with migraine/month; and other clinical variables, mood scores, and cardiorespiratory fitness were chosen as tertiary outcomes. Measurements were taken on headache-free days. Data were analyzed by generalized linear models. Discussion: Fifty participants concluded the study (mean±SD age=36.2±10.9, and BMI=26.5±4.5). The plasma AEA reduced in migraine exercise (p<0.05) and control exercise groups (p<0.01). The number of days with migraine (p<0.01), migraine attacks (p<0.05), and abortive medication used (p<0.05) reduced in the migraine exercise group, whereas cardiorespiratory fitness increased in migraine exercise and control exercise groups (both p<0.05). Anxiety, depression, anger, and fatigue scores improved in the migraine exercise group (p<0.05 for all). Significant correlations between reduction in abortive medication used and cardiorespiratory fitness (r=-0.81 p<0.001), and reduced AEA (r=0.68 p<0.05) were found. Conclusions: This study suggests that peripheral AEA metabolism may be partly linked to the clinical and cardiorespiratory benefits of regular aerobic exercise in migrainepatients. Trials registration: #NCT01972607. Copyright 2019, Mary Ann Liebert, Inc., publishers.
Authors: Paola Sarchielli; Luigi Alberto Pini; Francesca Coppola; Cristiana Rossi; Antonio Baldi; Maria Luisa Mancini; Paolo Calabresi Journal: Neuropsychopharmacology Date: 2006-11-22 Impact factor: 7.853
Authors: Isabelle Boutron; David Moher; Douglas G Altman; Kenneth F Schulz; Philippe Ravaud Journal: Ann Intern Med Date: 2008-02-19 Impact factor: 25.391
Authors: Shreya Desai; Breanna Borg; Carrie Cuttler; Kevin M Crombie; Christine A Rabinak; Matthew N Hill; Hilary A Marusak Journal: Cannabis Cannabinoid Res Date: 2021-12-03
Authors: Álvaro Reina-Varona; Borja Rodríguez de Rivera-Romero; Carlos Donato Cabrera-López; José Fierro-Marrero; Irene Sánchez-Ruiz; Roy La Touche Journal: PeerJ Date: 2022-09-30 Impact factor: 3.061